The FDA has taken action against 17 companies that are illegally selling unapproved and/or misbranded products that claim to prevent, treat, or cure Alzheimer disease and other serious diseases and health conditions.
Crenezumab is an investigational monoclonal antibody that preferentially binds to and promotes the removal of neurotoxic oligomers, a form of beta-amyloid.
Older people who have less slow wave sleep have higher levels of the brain protein tau, a marker of brain damage and Alzheimer disease.
Nearly all older adults with Down syndrome now have dementia when they die, making this a vital population to study disease progression, modifying factors, and potential treatments.
Certain molecular biomarkers for Alzheimer disease differ with race.
Researchers examined the safety, tolerability, and feasibility of young plasma infusion in patients with mild to moderate Alzheimer disease dementia in an Alzheimer’s symptom amelioration study.
The concomitant use of cholinesterase inhibitors or memantine was associated with an increased rate of cognitive decline in clinical trials of patients with Alzheimer disease.
Investigators analyzed medial temporal lobe structure, white matter lesion load, and β-amyloid deposition in women who underwent bilateral salpingo-oophorectomy prior to reaching natural menopause.
Researchers investigated a link between higher levels of the stress hormone cortisol and deficient memory skills in people without dementia.
Women with military-related risk factors have an increased risk for developing dementia.